Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADIL | AZN | AMGN | GILD | VRTX |
| Company | Adial Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.6900 | 66.95 | 275.70 | 104.89 | 483.83 |
| High | 0.7090 | 68.43 | 278.73 | 106.44 | 491.80 |
| Low | 0.6600 | 66.87 | 274.49 | 104.78 | 480.56 |
| Last | 0.6778 | 67.87 | 278.40 | 105.51 | 490.47 |
| Change | +0.0278 | +0.97 | +4.72 | +1.18 | +12.95 |
| % Change | +4.28% | +1.45% | +1.72% | +1.13% | +2.71% |
| Volume | 35,600 | 5,806,900 | 2,080,900 | 7,540,700 | 1,131,500 |
| 20-Day Average Volume | 53,245 | 6,811,315 | 3,224,570 | 9,327,230 | 1,683,455 |
| Previous Close | 0.6500 | 66.90 | 273.68 | 104.33 | 477.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6933 | 69.35 | 294.17 | 107.27 | 487.22 |
| 20-Day Raw Stochastic | 45.49% | 45.85% | 23.11% | 46.99% | 65.56% |
| 20-Day Relative Strength | 45.25% | 43.00% | 40.61% | 47.79% | 52.10% |
| Weighted Alpha | -56.82 | -12.10 | -3.46 | +57.36 | +19.63 |
| Today's Opinion | 100% Sell | 72% Sell | 56% Sell | 40% Buy | 72% Buy |
| Previous Opinion | 100% Sell | 72% Sell | 56% Sell | 40% Buy | 40% Buy |
| Last Month's Opinion | 100% Sell | 40% Buy | 56% Buy | 80% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.48% since 04/14/25 | -0.21% since 04/14/25 | -5.28% since 04/14/25 | -0.93% since 04/14/25 | -1.08% since 04/14/25 |
| Low | 0.6500 on 04/21/25 | 66.59 on 04/21/25 | 268.50 on 04/17/25 | 103.09 on 04/21/25 | 472.90 on 04/21/25 |
| High | 0.7350 on 04/21/25 | 68.43 on 04/22/25 | 296.17 on 04/15/25 | 106.50 on 04/15/25 | 502.22 on 04/16/25 |
| 1-Month | |||||
| %Chg | -8.16% since 03/21/25 | -9.42% since 03/21/25 | -11.91% since 03/21/25 | -1.47% since 03/21/25 | -2.53% since 03/21/25 |
| Low | 0.5800 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 97.32 on 04/09/25 | 448.14 on 04/07/25 |
| High | 0.7950 on 04/08/25 | 75.70 on 04/03/25 | 317.58 on 03/24/25 | 114.75 on 04/03/25 | 513.97 on 03/24/25 |
| 3-Month | |||||
| %Chg | -29.69% since 01/22/25 | -0.48% since 01/22/25 | +1.81% since 01/22/25 | +13.40% since 01/22/25 | +14.60% since 01/22/25 |
| Low | 0.5800 on 04/07/25 | 61.24 on 04/09/25 | 267.40 on 04/09/25 | 92.21 on 01/23/25 | 424.54 on 01/23/25 |
| High | 1.3000 on 02/25/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.68 on 03/14/25 |
| 6-Month | |||||
| %Chg | -42.07% since 10/22/24 | -12.22% since 10/22/24 | -12.91% since 10/22/24 | +19.68% since 10/22/24 | +3.28% since 10/22/24 |
| Low | 0.5800 on 04/07/25 | 61.24 on 04/09/25 | 253.30 on 12/19/24 | 86.08 on 11/19/24 | 377.85 on 12/19/24 |
| High | 1.3000 on 02/25/25 | 78.36 on 03/05/25 | 335.88 on 03/10/25 | 119.96 on 03/10/25 | 519.88 on 11/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,273 | 207,473,440 | 147,144,320 | 129,907,848 | 122,622,360 |
| Shares Outstanding, K | 6,575 | 3,101,247 | 537,651 | 1,245,163 | 256,790 |
| Annual Sales | 0 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -13,200,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 14,891,000,000 | 9,086,000,000 | 7,569,000,000 | 2,912,000,000 |
| Last Quarter Net Income | -2,070,000 | 1,499,000,000 | 627,000,000 | 1,783,000,000 | 913,000,000 |
| 60-Month Beta | 1.26 | 0.49 | 0.59 | 0.32 | 0.50 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.15 on 03/04/25 | 1.05 on 02/06/25 | 5.31 on 02/04/25 | 1.90 on 02/11/25 | 3.98 on 02/10/25 |
| Latest Earnings Date | 05/13/25 | 04/29/25 | 05/01/25 | 04/24/25 | 05/05/25 |
| Most Recent Dividend | N/A | 1.030 on 02/21/25 | 2.380 on 02/14/25 | 0.790 on 03/14/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/21/25 | 05/16/25 | 03/14/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 16.45 | 13.99 | 22.68 | 0.00 |